Browse 18 Genetics companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
View all companies funded by RA Capital Management across every industry and funding stage.
View Full RA Capital Management Portfolio